10486111
|
Evidence that enviroxime targets multiple components of the rhinovirus 14 replication complex. |
Arch Virol |
1999 |
Brown-Augsburger P;Vance LM;Malcolm SK;Hsiung H;Smith DP;Heinz BA |
View
More |
10950388
|
Antiviral therapy for enteroviruses and rhinoviruses. |
Antivir Chem Chemother |
2000 |
Rotbart HA |
View
More |
12719275
|
Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo. |
Circulation |
2003 |
Pelat M;Dessy C;Massion P;Desager JP;Feron O;Balligand JL |
View
More |
15168800
|
Mode of action of 2-furylmercury chloride, an anti-rhinovirus compound. |
Antiviral Res |
2004 |
Verheyden B;Andries K;Rombaut B |
View
More |
16957557
|
Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels? |
J Hypertens |
2006 |
Aw TJ;Liew D;Tofler GH;Schneider HG;Morel-Kopp MC;Billah B;Krum H |
View
More |
19237651
|
Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. |
Antimicrob Agents Chemother |
2009 |
De Palma AM;Thibaut HJ;van der Linden L;Lanke K;Heggermont W;Ireland S;Andrews R;Arimilli M;Al-Tel TH;De Clercq E;van Kuppeveld F;Neyts J |
View
More |
21824825
|
COX-2 inhibition does not reverse the increased sympathetic modulation in MSG obese rats. |
Auton Neurosci |
2011 |
da Cunha NV;Pinge-Filho P;Barbosa Neto O;Grassiolli S;Martins-Pinge MC |
View
More |
22945356
|
Coxsackievirus mutants that can bypass host factor PI4KIIIbeta and the need for high levels of PI4P lipids for replication. |
Cell Res |
2012 |
van der Schaar HM;van der Linden L;Lanke KH;Strating JR;Purstinger G;de Vries E;de Haan CA;Neyts J;van Kuppeveld FJ |
View
More |
23164665
|
Nickel-regulated heart rate variability: the roles of oxidative stress and inflammation. |
Toxicol Appl Pharmacol |
2013 |
Chuang HC;Hsueh TW;Chang CC;Hwang JS;Chuang KJ;Yan YH;Cheng TJ |
View
More |
23650168
|
Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo. |
Antimicrob Agents Chemother |
2013 |
Spickler C;Lippens J;Laberge MK;Desmeules S;Bellavance E;Garneau M;Guo T;Hucke O;Leyssen P;Neyts J;Vaillancourt FH;Decor A;O'Meara J;Franti M;Gauthier A |
View
More |
24870364
|
A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases. |
J Med Chem |
2014 |
Kathman SG;Xu Z;Statsyuk AV |
View
More |
27063860
|
Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds. |
Antiviral Res |
2016 |
Smee DF;Evans WJ;Nicolaou KC;Tarbet EB;Day CW |
View
More |
28360114
|
RORalpha-dependent type 2 innate lymphoid cells are required and sufficient for mucous metaplasia in immature mice. |
Am J Physiol Lung Cell Mol Physiol |
2017 |
Rajput C;Cui T;Han M;Lei J;Hinde JL;Wu Q;Bentley JK;Hershenson MB |
View
More |
2843086
|
Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes. |
Antimicrob Agents Chemother |
1988 |
Wyde PR;Six HR;Wilson SZ;Gilbert BE;Knight V |
View
More |
2984980
|
Controlled trial of enviroxime against natural rhinovirus infections in a community. |
Antimicrob Agents Chemother |
1985 |
Miller FD;Monto AS;DeLong DC;Exelby A;Bryan ER;Srivastava S |
View
More |
2988431
|
Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4\',6-dichloroflavan, and enviroxime. |
Antimicrob Agents Chemother |
1985 |
Ninomiya Y;Aoyama M;Umeda I;Suhara Y;Ishitsuka H |
View
More |
2996687
|
Rhinovirus colds. |
Br Med Bull |
1985 |
Phillpotts RJ;Tyrrell DA |
View
More |
3002267
|
Antiviral agents against picornaviruses. |
Antiviral Res |
1985 |
Eggers HJ |
View
More |
3005577
|
Synthesis and antiviral activity of sulfonamidobenzophenone oximes and sulfonamidobenzamides. |
J Med Chem |
1986 |
Ogata M;Matsumoto H;Shimizu S;Kida S;Wada T;Shiro M;Sato K |
View
More |
3017203
|
Synergism between anti-rhinovirus antivirals: various human interferons and a number of synthetic compounds. |
Antiviral Res |
1986 |
Ahmad AL;Tyrrell DA |
View
More |
3025150
|
Molecular basis of drug resistance to new antirhinovirus agents. |
J Antimicrob Chemother |
1986 |
Ishitsuka H;Ninomiya Y;Suhara Y |
View
More |
3228281
|
Small particle aerosols of enviroxime-containing liposomes. |
Antiviral Res |
1988 |
Gilbert BE;Six HR;Wilson SZ;Wyde PR;Knight V |
View
More |
3232968
|
Failure to demonstrate synergy between interferon-alpha and a synthetic antiviral, enviroxime, in rhinovirus infections in volunteers. |
Antiviral Res |
1988 |
Higgins PG;Barrow GI;al-Nakib W;Tyrrell DA;DeLong DC;Lenox-Smith I |
View
More |
6113314
|
The activity of enviroxime against rhinovirus infection in man. |
Lancet |
1981 |
Phillpotts RJ;Jones RW;Delong DC;Reed SE;Wallace J;Tyrrell DA |
View
More |
6245149
|
Inhibition of rhinovirus replication in in organ culture by a potential antiviral drug. |
J Infect Dis |
1980 |
DeLong DC;Reed SE |
View
More |
6247489
|
Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-am ine. Inhibitors of rhinovirus multiplication. |
J Med Chem |
1980 |
Wikel JH;Paget CJ;DeLong DC;Nelson JD;Wu CY;Paschal JW;Dinner A;Templeton RJ;Chaney MO;Jones ND;Chamberlin JW |
View
More |
6287928
|
Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection. |
Antimicrob Agents Chemother |
1982 |
Hayden FG;Gwaltney JM Jr |
View
More |
6297380
|
Topical enviroxime against rhinovirus infection. |
Antimicrob Agents Chemother |
1982 |
Levandowski RA;Pachucki CT;Rubenis M;Jackson GG |
View
More |
6870216
|
Therapeutic activity of enviroxime against rhinovirus infection in volunteers. |
Antimicrob Agents Chemother |
1983 |
Phillpotts RJ;Wallace J;Tyrrell DA;Tagart VB |
View
More |
6927286
|
Antiviral activity of sodium 5-aminosulfonyl-2,4-dichlorobenzoate (M12325). |
Antimicrob Agents Chemother |
1982 |
Ohnishi H;Yamaguchi K;Shimada S;Himuro S;Suzuki Y |
View
More |
7769678
|
The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus. |
J Virol |
1995 |
Heinz BA;Vance LM |
View
More |
7988393
|
Literature review: the common cold. |
Ear Nose Throat J |
1994 |
Hilding DA |
View
More |
8676522
|
Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses. |
J Virol |
1996 |
Heinz BA;Vance LM |
View
More |
9341923
|
Synthesis and antiviral activity of C2 analogs of enviroxime: an exploration of the role of critical functionality. |
J Med Chem |
1997 |
Victor F;Loncharich R;Tang J;Spitzer WA |
View
More |